New pre-clinical evidence has demonstrated that breast milk is capable of attenuating the TLR4-mediated pro-inflammatory response integral to NEC pathogenesis by activating the receptor for epidermal growth factor (EGFR), revealing the interplay between the EGF pathway and the hallmark TLR4 signaling of NEC (95). This evidence concerns the gene EGF and necrotizing enterocolitis.